Schmidt, C <br/><br/>
Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  08 2016 
 - 259-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.13665  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Anemia, Iron-Deficiency--blood<br/>Colitis, Ulcerative--blood<br/>Crohn Disease--blood<br/>Double-Blind Method<br/>Female<br/>Ferric Compounds--administration & dosage<br/>Hemoglobins, Abnormal--metabolism<br/>Humans<br/>Inflammatory Bowel Diseases--blood<br/>Iron--administration & dosage<br/>Male<br/>Middle Aged<br/>Pyrones--administration & dosage